1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice


Discussion in 'Santarus' started by Anonymous, Aug 16, 2011 at 12:20 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest


  2. Anonymous

    Anonymous Guest

    Yoooo big boy its more like you are a loooooser and hope the door hit you on the way out. Heehee.
  3. Anonymous

    Anonymous Guest

    No one was kicking themselves when you left.
  4. Anonymous

    Anonymous Guest

    Dude really? All pharma basically sucks for the most part. Sanofi doesn't own that designation. Come on, come up with an original idea.
  5. Anonymous

    Anonymous Guest

    Amen to the above poster-DUH to OP
    Really-ask any SA employee and they will tell you this and provide documentation by the metric ton
  6. anonymous

    anonymous Guest

    How TRUE!